Nyxoah SA Price to Free Cash Flow Ratio 2021-2024 | NYXH
Historical price to free cash flow ratio values for Nyxoah SA (NYXH) since 2021.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Nyxoah SA Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-02-21 | 10.35 | 0.00 | |
| 2024-09-30 | 9.55 | $-1.69 | 0.00 |
| 2024-06-30 | 6.97 | $-1.79 | 0.00 |
| 2024-03-31 | 13.49 | $-1.84 | 0.00 |
| 2023-12-31 | 4.64 | $-1.83 | 0.00 |
| 2023-09-30 | 7.05 | $-1.82 | 0.00 |
| 2023-06-30 | 8.01 | $-1.68 | 0.00 |
| 2023-03-31 | 7.47 | $-1.42 | 0.00 |
| 2022-12-31 | 4.99 | $-1.21 | 0.00 |
| 2022-09-30 | 6.30 | $-0.74 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||